Trial Profile
Effect of prasugrel for stent implantation in patients with acute coronary syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Sep 2020
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Clopidogrel
- Indications Acute coronary syndromes
- Focus Pharmacodynamics
- Acronyms PACS study
- 22 Mar 2019 Status changed from active, no longer recruiting to completed.
- 03 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 21 Mar 2017 Planned End Date changed from 31 Dec 2015 to 31 Mar 2017.